Aug. 6, 2018—Sysmex America and Advanced Instruments announced a partnership that will broaden the Sysmex portfolio with Advanced Instruments’ automated GloCyte cell counter system. The GloCyte system uses a combination of fluorescence, microscopy with digital image analysis, highly specific reagents, and an intelligent counting algorithm to provide accurate counts down to zero for both red blood cell and total nucleated cell in cerebrospinal fluid in adult and pediatric patients.
“The addition of GloCyte makes our portfolio of diagnostic analyzers even more versatile, scalable, and customizable to the unique needs of the many laboratories and physicians who depend on them to provide patients with the very best in health care,” Andy Hay, COO of Sysmex America, said in a press release. “While diagnostic technology like our XN-3100 and XN-9100 provide highly accurate and reliable results for an array of health conditions, for laboratories testing CSF, adding GloCyte is a solution that provides accurate cell counts at clinically relevant low levels while offering maximum efficiency and minimum workflow disruption.”
Under the agreement, Sysmex America will be the exclusive distributor of GloCyte in the U.S., Canada, and Latin America.